The Role of Vitamins D, B12, C, and K in Modulating Inflammation and Disease Management in Rheumatoid Arthritis: a Comprehensive Review

Overview

Journal Clin Rheumatol

Publisher Springer

Specialty Rheumatology

Date 2024 Dec 25

PMID 39722107

Authors

Nawal Hijjawi

Faten S Tout

Baraah Azaizeh

Baraah Aljaafreh

Affiliations

Soon will be listed here.

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disorder marked by joint inflammation and destruction. Recent studies emphasize the importance of vitamins D, B12, C, and K in managing RA and enhancing patient health. Vitamin D deficiency is common in RA patients and correlates with increased disease severity, indicating its potential to modulate immune responses and reduce inflammation. Supplementation has shown promise in improving disease activity scores and lowering inflammatory markers. Vitamin B12 is vital for energy and neurological function; its deficiency can worsen fatigue in RA sufferers. Vitamin C, with its antioxidant properties, aids collagen synthesis and may reduce joint inflammation. Vitamin K, particularly through Matrix Gla-Protein (MGP), is essential for bone health and may help prevent joint calcification and osteoporosis. Collectively, these vitamins play critical roles in immune modulation, inflammation reduction, and bone health in RA management, warranting further research on optimal dosages and combinations for effective treatment strategies.

References

Figus F, Piga M, Azzolin I, McConnell R, Iagnocco A . Rheumatoid arthritis: Extra-articular manifestations and comorbidities. Autoimmun Rev. 2021; 20(4):102776. DOI: 10.1016/j.autrev.2021.102776. View

Bullock J, Rizvi S, Saleh A, Ahmed S, Do D, Ansari R . Rheumatoid Arthritis: A Brief Overview of the Treatment. Med Princ Pract. 2018; 27(6):501-507. PMC: 6422329. DOI: 10.1159/000493390. View

Myasoedova E, Davis J, Matteson E, Crowson C . Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985-2014. Ann Rheum Dis. 2020; 79(4):440-444. PMC: 7085464. DOI: 10.1136/annrheumdis-2019-216694. View

Watts R, Hatemi G, Burns J, Mohammad A . Global epidemiology of vasculitis. Nat Rev Rheumatol. 2021; 18(1):22-34. PMC: 8633913. DOI: 10.1038/s41584-021-00718-8. View

Finckh A, Gilbert B, Hodkinson B, Bae S, Thomas R, Deane K . Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022; 18(10):591-602. DOI: 10.1038/s41584-022-00827-y. View

Almoallim H, Al Saleh J, Badsha H, Ahmed H, Habjoka S, Menassa J . A Review of the Prevalence and Unmet Needs in the Management of Rheumatoid Arthritis in Africa and the Middle East. Rheumatol Ther. 2020; 8(1):1-16. PMC: 7991016. DOI: 10.1007/s40744-020-00252-1. View

Favalli E, Biggioggero M, Crotti C, Becciolini A, Raimondo M, Meroni P . Sex and Management of Rheumatoid Arthritis. Clin Rev Allergy Immunol. 2018; 56(3):333-345. DOI: 10.1007/s12016-018-8672-5. View

Catala M, Pino D, Marchena M, Palacios P, Urdiales T, Cardona P . Robust estimation of diagnostic rate and real incidence of COVID-19 for European policymakers. PLoS One. 2021; 16(1):e0243701. PMC: 7790392. DOI: 10.1371/journal.pone.0243701. View

Chiang Y, Yen Y, Chang W, Cheng K, Chang W, Chen H . The association between urbanization and rheumatoid arthritis in Taiwan. Int J Clin Pharmacol Ther. 2015; 54(1):1-10. DOI: 10.5414/CP202306. View

10.

Aletaha D, Smolen J . Diagnosis and Management of Rheumatoid Arthritis: A Review. JAMA. 2018; 320(13):1360-1372. DOI: 10.1001/jama.2018.13103. View

11.

Marshall M, Watt F, Vincent T, Dziedzic K . Hand osteoarthritis: clinical phenotypes, molecular mechanisms and disease management. Nat Rev Rheumatol. 2018; 14(11):641-656. DOI: 10.1038/s41584-018-0095-4. View

12.

Brouwer M, van de Schoor F, Vrijmoeth H, Netea M, Joosten L . A joint effort: The interplay between the innate and the adaptive immune system in Lyme arthritis. Immunol Rev. 2020; 294(1):63-79. PMC: 7065069. DOI: 10.1111/imr.12837. View

13.

Firestein G, McInnes I . Immunopathogenesis of Rheumatoid Arthritis. Immunity. 2017; 46(2):183-196. PMC: 5385708. DOI: 10.1016/j.immuni.2017.02.006. View

14.

van Delft M, Huizinga T . An overview of autoantibodies in rheumatoid arthritis. J Autoimmun. 2020; 110:102392. DOI: 10.1016/j.jaut.2019.102392. View

15.

Ronnelid J, Turesson C, Kastbom A . Autoantibodies in Rheumatoid Arthritis - Laboratory and Clinical Perspectives. Front Immunol. 2021; 12:685312. PMC: 8161594. DOI: 10.3389/fimmu.2021.685312. View

16.

Terao C, Brynedal B, Chen Z, Jiang X, Westerlind H, Hansson M . Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological Subphenotype. Am J Hum Genet. 2019; 105(3):616-624. PMC: 6731376. DOI: 10.1016/j.ajhg.2019.08.002. View

17.

Kurowska W, Kuca-Warnawin E, Radzikowska A, Maslinski W . The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis. Cent Eur J Immunol. 2018; 42(4):390-398. PMC: 5820977. DOI: 10.5114/ceji.2017.72807. View

18.

Rantapaa Dahlqvist S, Andrade F . Individuals at risk of seropositive rheumatoid arthritis: the evolving story. J Intern Med. 2019; 286(6):627-643. PMC: 6878216. DOI: 10.1111/joim.12980. View

19.

Okada Y, Eyre S, Suzuki A, Kochi Y, Yamamoto K . Genetics of rheumatoid arthritis: 2018 status. Ann Rheum Dis. 2018; 78(4):446-453. DOI: 10.1136/annrheumdis-2018-213678. View

20.

Zhao J, Stacey D, Eriksson N, Macdonald-Dunlop E, Hedman A, Kalnapenkis A . Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat Immunol. 2023; 24(9):1540-1551. PMC: 10457199. DOI: 10.1038/s41590-023-01588-w. View